Chemical Compound
(2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid a methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate a ethyl acetate (1:1:1);(2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid a methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate a ethyl acetate (1:1:1)
CAS Registry Number
2244994-24-7
Primary record
(2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid a methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate a ethyl acetate (1:1:1);(2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid a methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate a ethyl acetate (1:1:1)
- 库存
- 4,469 克
- 纯度
- 99.4 %
- CAS
- 2244994-24-7
化合物标识与属性
- CAS
- 2244994-24-7
- PubChem CID
- 156594230
- SMILES
- CCOC(=O)C.CC1=CC=C(C=C1)C(=O)O[C@@H]([C@@H](C(=O)O)OC(=O)C2=CC=C(C=C2)C)C(=O)O.COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)OC
- Canonical SMILES
- CCOC(C)=O.COC(=O)C[C@H]1c2cccc(F)c2N=C(N2CCN(c3cccc(OC)c3)CC2)N1c1cc(C(F)(F)F)ccc1OC.Cc1ccc(C(=O)O[C@H](C(=O)O)[C@H](OC(=O)c2ccc(C)cc2)C(=O)O)cc1
名称与同义词
- Letermovir Impurity 20
- Letermovir Impurity 34
- BBN35P2CJ3
- DTXSID901377623
- 2244994-24-7
- Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with ethyl acetate and methyl 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1:1)
- 2241754-97-0
- (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinic acid--ethyl acetate--methyl (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (1/1/1)
- (2S,3S)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid; ethyl acetate; methyl (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (1:1:1)
- (2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid a methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate a ethyl acetate (1:1:1);(2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid a methyl {(4S)-8-fluoro-2-[4-(3methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4yl}acetate a ethyl acetate (1:1:1)
- (2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid, ethyl acetate and methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1:1)
- (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid;ethyl acetate;methyl 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate